uniQure N.V.
NASDAQ:QUREBiotechnology
-$1.13 today
- Market cap
- $1.42B
- Beta
- 1.00
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$3.33
Volume 1.13M
Average 1.75M
QURE Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
uniQure N.V.NASDAQ: QURE
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin widens to 93.9%
Gross margin was 93.9% in Q1 FY2026, up 6.4 pp from a year earlier. On a trailing-twelve-month basis it was 74.1%, up 20.2 pp year over year. Over 3 fiscal years it narrowed by 7.3 pp.
Context
- Gross margin widened in 2 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 89.5%
- Year-over-year change
- +57.1pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 89.5% | +57.1pp |
| FY2024 | 2024-12-31 | 32.4% | +18.4pp |
| FY2023 | 2023-12-31 | 14.0% | -82.9pp |
| FY2022 | 2022-12-31 | 96.9% | +1.6pp |
| FY2021 | 2021-12-31 | 95.2% | — |
Gross Margin vs competitors
How QURE compares with its peers on the latest reported figures
- QURE's LTM Mar 2026 gross margin of 74.1% is the 3rd highest of the 6 companies compared; the peer median is -0.1%.
- Its year-over-year change of +20.2 pp is the 3rd highest of 6, against a peer median of +2.3 pp.
- Over three fiscal years its change of -7.3 pp compares with a peer median of +36.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 91.6% | +64.6 pp | -6.0 pp | |
| LTM Mar 2026 | 83.6% | -1.6 pp | -8.4 pp | |
| LTM Mar 2026 | 74.1% | +20.2 pp | -7.3 pp | |
| LTM Mar 2026 | -0.1% | -76.7 pp | +36.5 pp | |
| LTM Mar 2026 | -12.4% | +490439.7 pp | +2555.9 pp | |
| LTM Mar 2026 | -86.7% | +2.3 pp | +136.3 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding QURE) | -0.1% | +2.3 pp | +36.5 pp | |
Competitors are the stored peer set for QURE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 524M | 106.48M | 15.84M | 27.12M | 16.1M |
| Cost of Revenue | 24.98M | 3.34M | 13.63M | 18.33M | 1.69M |
| Gross Profit | 499.03M | 103.14M | 2.22M | 8.79M | 14.41M |
| Gross Margin | 95.2% | 96.9% | 14.0% | 32.4% | 89.5% |
| Research & Development | 143.55M | 197.59M | 214.86M | 143.78M | 140.67M |
| Selling, General & Admin | 56.29M | 54.7M | 73.08M | 50.68M | 65.34M |
| Operating Expenses | 188.41M | 246.3M | 285.09M | 193.09M | 202.24M |
| Depreciation & Amortization | 7.3M | 8.54M | 11.9M | 12.64M | 14.76M |
| EBITDA | 319M | (108.02M) | (253.1M) | (160.75M) | (116.59M) |
| EBITDA Margin | 60.9% | -101.4% | -1597.6% | -592.7% | -724.2% |
| Operating Income | 310.62M | (143.16M) | (282.87M) | (184.29M) | (187.83M) |
| Operating Margin | 59.3% | -134.4% | -1785.5% | -679.6% | -1166.8% |
| Interest Income | 162K | 609K | 19.56M | 21.42M | 16.97M |
| Interest Expense | 7.47M | 11.7M | 41.56M | 63.74M | 61.99M |
| Other Income / Expenses | 22.19M | 14.9M | (23.69M) | (52.83M) | (5.51M) |
| Income Before Tax | 332.81M | (128.26M) | (306.56M) | (237.13M) | (193.34M) |
| Pre-Tax Margin | 63.5% | -120.5% | -1935.0% | -874.4% | -1201.0% |
| Income Tax Expense | 3.22M | (1.47M) | 1.92M | 2.43M | 5.63M |
| Net Income | 329.59M | (126.79M) | (308.48M) | (239.56M) | (198.97M) |
| Net Margin | 62.9% | -119.1% | -1947.1% | -883.4% | -1236.0% |
| EPS (Basic) | 7.17 | (2.71) | (6.47) | (4.92) | (3.46) |
| EPS (Diluted) | 7.04 | (2.71) | (6.47) | (4.92) | (3.46) |
| Weighted Avg Shares | 45.99M | 46.74M | 47.67M | 48.65M | 57.5M |
| Weighted Avg Shares (Diluted) | 46.84M | 46.74M | 47.67M | 48.65M | 57.5M |
uniQure N.V.
NASDAQ:QURE
Intrinsic Alpha fair value
Locked
Current Price
$20.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.